Effects of ONO-2506PO in Patients With Alzheimer's Disease

A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

NCT00930059 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

NCT03462121 ·Status: COMPLETED ·Phase: PHASE2

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

NCT02565511 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

NCT03131453 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001

NCT01760005 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

NCT01266525 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)

NCT01600859 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease

NCT02260674 ·Status: COMPLETED ·Phase: PHASE2

ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

NCT04488419 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

NCT00105547 ·Status: COMPLETED ·Phase: PHASE3

An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum

NCT02406027 ·Status: TERMINATED ·Phase: PHASE2

Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease

NCT00842673 ·Status: COMPLETED ·Phase: PHASE2

Assessment Of The Effects Of Single Doses Of An Investigational Drug, Given Alone Or With Donepezil, On Scopolamine-Induced Changes In Memory And Learning In Healthy Adults

NCT01345864 ·Status: TERMINATED ·Phase: PHASE1

A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients

NCT02648906 ·Status: UNKNOWN ·Phase: PHASE4

A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People

NCT06367426 ·Status: RECRUITING ·Phase: PHASE1

Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)

NCT01181310 ·Status: COMPLETED ·Phase: PHASE1

Study of the Effect of SR57667B in Patients With Alzheimer's Disease

NCT00285025 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill

NCT06597058 ·Status: COMPLETED ·Phase: PHASE2

Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease

NCT00733642 ·Status: COMPLETED ·Phase: PHASE1

Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease

NCT04693520 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

NCT02615002 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease

NCT07214727 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease

NCT07328451 ·Status: RECRUITING ·Phase: PHASE1

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

NCT06079190 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07

NCT02434666 ·Status: COMPLETED ·Phase: PHASE2